ATE203277T1 - Verfahren zur bestimmung der wirksamkeit einer testsubstanz - Google Patents
Verfahren zur bestimmung der wirksamkeit einer testsubstanzInfo
- Publication number
- ATE203277T1 ATE203277T1 AT94112272T AT94112272T ATE203277T1 AT E203277 T1 ATE203277 T1 AT E203277T1 AT 94112272 T AT94112272 T AT 94112272T AT 94112272 T AT94112272 T AT 94112272T AT E203277 T1 ATE203277 T1 AT E203277T1
- Authority
- AT
- Austria
- Prior art keywords
- coagulation factor
- factor xii
- blood coagulation
- blood
- tested substance
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
- C12Q2337/10—Anilides
- C12Q2337/12—Para-Nitroanilides p-NA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96458—Factor XII (3.4.21.38)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21517793A JP3213831B2 (ja) | 1993-08-06 | 1993-08-06 | 被検物質の活性測定方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE203277T1 true ATE203277T1 (de) | 2001-08-15 |
Family
ID=16667948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94112272T ATE203277T1 (de) | 1993-08-06 | 1994-08-05 | Verfahren zur bestimmung der wirksamkeit einer testsubstanz |
Country Status (8)
Country | Link |
---|---|
US (1) | US5599683A (de) |
EP (1) | EP0637633B1 (de) |
JP (1) | JP3213831B2 (de) |
KR (1) | KR100270161B1 (de) |
CN (1) | CN1080763C (de) |
AT (1) | ATE203277T1 (de) |
DE (1) | DE69427723T2 (de) |
ES (1) | ES2159535T3 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1084995A (ja) * | 1996-09-12 | 1998-04-07 | Nippon Zoki Pharmaceut Co Ltd | 血液凝固第xii因子活性化法 |
US6632678B2 (en) | 2001-01-03 | 2003-10-14 | Sienco, Inc. | Method for performing activated clotting time test with reduced sensitivity to the presence of aprotinin and for assessing aprotinin sensitivity |
US6913900B2 (en) | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
US20030143444A1 (en) * | 2002-01-31 | 2003-07-31 | Qin Liu | Fuel cell with fuel droplet fuel supply |
US20060024745A1 (en) * | 2002-12-20 | 2006-02-02 | Pritchard David J | Variants of factor XllA |
RU2504771C2 (ru) * | 2011-06-29 | 2014-01-20 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО ПГФА Росздрава) | Способ отбора анальгетических средств |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB697351A (en) * | 1951-01-16 | 1953-09-23 | Masuichi Takino | Improved process for the manufacture of nerve sedatives |
JPS53101515A (en) * | 1977-02-17 | 1978-09-05 | Nippon Zoki Pharmaceutical Co | Medicine having anodyne * sedative and antiallergic activity and production thereof |
JPS5777697A (en) * | 1980-11-04 | 1982-05-15 | Nippon Zoki Pharmaceut Co Ltd | Physiologically active substance nsq |
JPS5835117A (ja) * | 1981-08-25 | 1983-03-01 | Nippon Zoki Pharmaceut Co Ltd | 新規生理活性物質nsh |
ATE17262T1 (de) * | 1981-11-02 | 1986-01-15 | Pentapharm Ag | Verfahren zur quantitativen bestimmung von blutgerinnungsfaktor xii in humanplasma. |
DE3504405A1 (de) * | 1985-02-08 | 1986-08-14 | Boehringer Mannheim Gmbh, 6800 Mannheim | Bestimmung von prokallikrein |
JPS63185398A (ja) * | 1986-09-10 | 1988-07-30 | Nippon Zoki Pharmaceut Co Ltd | 生理活性物質測定法 |
US4882272A (en) * | 1986-10-01 | 1989-11-21 | Temple University - Of The Commonwealth System Of Higher Education | High molecular weight kininogen assay |
JP2651674B2 (ja) * | 1987-07-23 | 1997-09-10 | 日本臓器製薬 株式会社 | 新規生理活性物質及びその製造方法 |
US4985254A (en) * | 1987-11-06 | 1991-01-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Method of treating ischemic diseases |
EP0341209B1 (de) * | 1988-04-30 | 1993-09-15 | Nippon Zoki Pharmaceutical Co. Ltd. | Physiologisch wirkende Substanzen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen davon |
JP2539665B2 (ja) * | 1988-06-20 | 1996-10-02 | 日本臓器製薬株式会社 | 神経疾患治療剤 |
CA2082643A1 (en) * | 1990-05-10 | 1991-11-11 | Jan H. Nuijens | Inhibitors of factor xii activation and applications thereof |
-
1993
- 1993-08-06 JP JP21517793A patent/JP3213831B2/ja not_active Expired - Fee Related
-
1994
- 1994-07-25 KR KR1019940018000A patent/KR100270161B1/ko not_active IP Right Cessation
- 1994-08-04 US US08/283,200 patent/US5599683A/en not_active Expired - Fee Related
- 1994-08-05 ES ES94112272T patent/ES2159535T3/es not_active Expired - Lifetime
- 1994-08-05 AT AT94112272T patent/ATE203277T1/de not_active IP Right Cessation
- 1994-08-05 DE DE69427723T patent/DE69427723T2/de not_active Expired - Fee Related
- 1994-08-05 CN CN94115040A patent/CN1080763C/zh not_active Expired - Fee Related
- 1994-08-05 EP EP94112272A patent/EP0637633B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0637633B1 (de) | 2001-07-18 |
EP0637633A2 (de) | 1995-02-08 |
CN1110409A (zh) | 1995-10-18 |
DE69427723T2 (de) | 2002-05-08 |
EP0637633A3 (de) | 1998-01-07 |
US5599683A (en) | 1997-02-04 |
KR100270161B1 (ko) | 2000-10-16 |
DE69427723D1 (de) | 2001-08-23 |
KR950006461A (ko) | 1995-03-21 |
ES2159535T3 (es) | 2001-10-16 |
JPH0751097A (ja) | 1995-02-28 |
JP3213831B2 (ja) | 2001-10-02 |
CN1080763C (zh) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69018910D1 (de) | Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren. | |
DE3788762D1 (de) | Verfahren zur Bestimmung von physiologisch wirksamen Substanzen. | |
CA2252983A1 (en) | Method for determining the anticoagulatory potential of a sample | |
DE59409698D1 (de) | Verfahren zur Bestimmung der Thrombozytenaggregation | |
US20210071229A1 (en) | Fibrinogen test | |
ES2152531T3 (es) | Prueba para determinar el riesgo de trombosis. | |
ATE203277T1 (de) | Verfahren zur bestimmung der wirksamkeit einer testsubstanz | |
EP1367135A1 (de) | Verbessertes Verfahren zur Beurteilung der Thrombinbildung in Blutplasma | |
US4918001A (en) | Method for the determination of protease inhibitors | |
DE60009879T2 (de) | Bestimmung von biologisch aktiven formen von proteolytischen enzymen | |
ATE136367T1 (de) | Verfahren zur bestimmung von hirudin und synthetischen trhombininhibitoren | |
ATE194659T1 (de) | Verfahren zur prüfung der wirksamkeit einer testsubstanz | |
ATA99992A (de) | Verfahren zur bestimmung von fibrinogen | |
ATE191278T1 (de) | Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen | |
Nishikawa et al. | Method for measuring production activity of test substance towards FXIIA | |
ATE208504T1 (de) | Komplex-gebundene hemmstoffe aktivierbarer stoffwechselenzyme als molekulare marker zur diagnostik und therapieüberwachung | |
CZ88093A3 (en) | Application of prothrombin fragments | |
ATE213274T1 (de) | Verfahren zur beurteilung der aktivität von arzneistoffen | |
Hertfelder et al. | Evaluation of normal values for fibrin monomers, thrombin-antithrombin III-complex, t-PA-and PAI-activities in human plasma | |
Kirchhof et al. | Early detection of DIC by screening methods | |
Holtkötter et al. | Determination of fibrin monomers in pathological plasma samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee |